These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
888 related items for PubMed ID: 7681784
1. Differential responses of myeloid progenitor cells from patients with myeloid leukemia and myelodysplasia to the costimulating effects of steel factor in vitro. Maze R, Horie M, Hendrie P, Vadhan-Raj S, Tricot G, Gordon M, Nemunaitis J, Ashman LK, Broxmeyer HE. Exp Hematol; 1993 Apr; 21(4):545-51. PubMed ID: 7681784 [Abstract] [Full Text] [Related]
7. Effect of recombinant human stem cell factor on mafosfamide-treated bone marrow clonogenic cells. Carlo-Stella C, Mangoni L, Almici C, Caramatti C, Rizzoli V. Stem Cells; 1993 Jul; 11 Suppl 2():170-4. PubMed ID: 7691323 [Abstract] [Full Text] [Related]
8. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia. Wisniewski D, Strife A, Atzpodien J, Clarkson BD. Cancer Res; 1987 Sep 15; 47(18):4788-94. PubMed ID: 3040231 [Abstract] [Full Text] [Related]
9. Comparison of in vivo and in vitro effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with acute myeloid leukemia. Estrov Z, Estey EH, Andreeff M, Talpaz M, Kurzrock R, Reading CL, Deisseroth AB, Gutterman JU. Exp Hematol; 1992 Jun 15; 20(5):558-64. PubMed ID: 1587302 [Abstract] [Full Text] [Related]
11. Growth characteristics of marrow hematopoietic progenitor/precursor cells from patients on a phase I clinical trial with purified recombinant human granulocyte-macrophage colony-stimulating factor. Broxmeyer HE, Cooper S, Williams DE, Hangoc G, Gutterman JU, Vadhan-Raj S. Exp Hematol; 1988 Aug 15; 16(7):594-602. PubMed ID: 3260558 [Abstract] [Full Text] [Related]
12. [Enhanced sensitivity to cytosine arabinoside by combined stimulation of steel factor and GM-CSF in a factor-dependent leukemic cell line, MO7e--in terms of a possible clinical application to AML treatment]. Gotoh A, Kawanishi Y, Kurosawa K, Miyazawa K, Ohtaka M, Aizawa S, Kimura Y, Yoshikawa O, Toyama K. Rinsho Ketsueki; 1993 Jul 15; 34(7):821-8. PubMed ID: 7689660 [Abstract] [Full Text] [Related]
15. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor. Lemoli RM, Fogli M, Fortuna A, Motta MR, Rizzi S, Benini C, Tura S. Exp Hematol; 1993 Dec 15; 21(13):1668-72. PubMed ID: 7694867 [Abstract] [Full Text] [Related]
16. Thymic humoral factor-gamma 2, an immunoregulatory peptide, enhances human hematopoietic progenitor cell growth. Barak Y, Hahn T, Pecht M, Karov Y, Berrebi A, Zaizov R, Stark B, Buchner V, Burstein Y, Trainin N. Exp Hematol; 1992 Feb 15; 20(2):173-7. PubMed ID: 1544385 [Abstract] [Full Text] [Related]
17. Differential effects of TGF-beta 1 on normal and leukemic human hematopoietic cell proliferation. Murohashi I, Endho K, Nishida S, Yoshida S, Jinnai I, Bessho M, Hirashima K. Exp Hematol; 1995 Aug 15; 23(9):970-7. PubMed ID: 7543418 [Abstract] [Full Text] [Related]
18. IL-11 in combination with SLF and G-CSF or GM-CSF significantly increases expansion of isolated CD34+ cell population from cord blood vs. adult bone marrow. van de Ven C, Ishizawa L, Law P, Cairo MS. Exp Hematol; 1995 Nov 15; 23(12):1289-95. PubMed ID: 7589284 [Abstract] [Full Text] [Related]
19. Effects of recombinant human granulocyte colony stimulating factor and granulocyte-monocyte colony stimulating factor on in vitro hemopoiesis in the myelodysplastic syndromes. Nagler A, Ginzton N, Negrin R, Bang D, Donlon T, Greenberg P. Leukemia; 1990 Mar 15; 4(3):193-202. PubMed ID: 1690318 [Abstract] [Full Text] [Related]
20. Kinetic response of human marrow myeloid progenitor cells to in vivo treatment of patients with granulocyte colony-stimulating factor is different from the response to treatment with granulocyte-macrophage colony-stimulating factor. Broxmeyer HE, Benninger L, Patel SR, Benjamin RS, Vadhan-Raj S. Exp Hematol; 1994 Jan 15; 22(1):100-2. PubMed ID: 7506671 [Abstract] [Full Text] [Related] Page: [Next] [New Search]